Create Account | Sign In: Author or Forum

 
 
News  |  Journals  |  Conferences  |  Blogs  |  Articles  |  Forums  |  Twitter    
 

 Headlines:

 

Category: Dermatology | Monthly Briefing

Back to Journal Articles

April 2010 Briefing - Dermatology

Last Updated: May 03, 2010.

 

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 

Here are what the editors at HealthDay consider to be the most important developments in Dermatology for April 2010. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.

Risk Factors for Physician Misconduct Identified

WEDNESDAY, April 28 (HealthDay News) -- Doctors who are male, are from lower socioeconomic groups or had academic difficulties in medical school may be at increased risk of professional misconduct, according to a study published online April 27 in BMJ.

Abstract
Full Text
Editorial

FDA Changes Medical Device Advisory Committee Process

TUESDAY, April 27 (HealthDay News) -- Because of the increasing number of medical device advisory panel meetings in recent years, the U.S. Food and Drug Administration is changing the way expert panels review and discuss information during public hearings on devices that are being reviewed for premarket approval.

More Information

Financial Ties Negatively Affect Perceptions of Research Quality

TUESDAY, April 27 (HealthDay News) -- Disclosure of financial ties to industry influences patients', physicians', and research participants' beliefs about the quality of research evidence, according to a review published in the April 26 issue of the Archives of Internal Medicine.

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

T. Tonsurans Rate High in Black Children in Kansas City

THURSDAY, April 22 (HealthDay News) -- Of Kansas City schoolchildren tested for Trichophyton tonsurans infection, 6.6 percent exhibited positive cultures, and black children had the highest prevalence of infection, according to a study published online April 19 in Pediatrics.

Abstract
Full Text (subscription or payment may be required)

Susceptibility Loci Identified for Generalized Vitiligo

WEDNESDAY, April 21 (HealthDay News) -- There are associations between generalized vitiligo and markers implicating multiple genes, including some associated with other autoimmune diseases and one -- TYR -- that may mediate target-cell specificity and indicate a mutually exclusive relationship between susceptibility to vitiligo and susceptibility to melanoma, according to a study published online April 21 in the New England Journal of Medicine.

Abstract
Full Text

E-visits for Acne Patient Follow-Up Found Effective

WEDNESDAY, April 21 (HealthDay News) -- Follow-up care for acne patients delivered via online visits, or "e-visits," results in an equivalent outcome clinically compared with conventional office visits, according to a study in the April issue of the Archives of Dermatology.

Abstract
Full Text (subscription or payment may be required)

Shared Appointments Improve Census, Profit in Dermatology

TUESDAY, April 20 (HealthDay News) -- In dermatology practices, shared medical appointments (SMAs) can increase patient access and productivity and be financially profitable, according to research published in the April issue of the Archives of Dermatology.

Abstract
Full Text (subscription or payment may be required)

Indoor Tanning Addiction Observed in College Students

TUESDAY, April 20 (HealthDay News) -- Many college students meet the criteria for addiction to indoor tanning, which is also associated with an increased likelihood of anxiety and substance use, according to a study published in the April issue of the Archives of Dermatology.

Abstract
Full Text (subscription or payment may be required)

Autoantibodies of Little Prognostic Value in Melanoma

THURSDAY, April 15 (HealthDay News) -- In melanoma patients who are treated with adjuvant pegylated interferon alfa-2b, the appearance of autoimmune antibodies is not a prognostic or predictive factor for improved outcome, according to research published online April 12 in the Journal of Clinical Oncology.

Abstract
Full Text (subscription or payment may be required)

Newly Found Gene Implicated in Hair Loss Condition

THURSDAY, April 15 (HealthDay News) -- Researchers have discovered a genetic mutation that appears to be involved in hair loss in people with hereditary hypotrichosis simplex and perhaps other hair loss conditions, according to research published in the April 15 issue of Nature.

Abstract
Full Text (subscription or payment may be required)

Accelerated Radiotherapy Has Potential for Poor Countries

WEDNESDAY, April 14 (HealthDay News) -- Accelerated fractionation of radiotherapy is an effective alternative to conventional fractionation for squamous-cell carcinoma of the head and neck (HNSCC) in developing countries, according to research published online April 9 in The Lancet Oncology.

Abstract
Full Text (subscription or payment may be required)

FDA Updates Web Site With Triclosan Information

THURSDAY, April 8 (HealthDay News) -- The U.S. Food and Drug Administration has updated its Web site (www.fda.gov) with information about triclosan, a common ingredient used in many consumer products -- including antibacterial soaps and body washes, toothpastes, and some cosmetics -- to reduce or prevent bacterial contamination.

More Information

Recurrence Unlikely for Many Biopsied Melanocytic Nevi

MONDAY, April 5 (HealthDay News) -- In patients who undergo biopsy of benign to moderately dysplastic melanocytic nevi, there is a low rate of clinical recurrence, so re-excision may not be necessary, according to a study in the April issue of the Journal of the American Academy of Dermatology.

Abstract
Full Text (subscription or payment may be required)

Changes in Photoallergic Contact Dermatitis Identified

MONDAY, April 5 (HealthDay News) -- Over the past 20 years, sunscreens and antimicrobial agents have been the most frequent allergens causing photoallergic contact dermatitis (PACD), while the number of reactions to medications has increased and PACD caused by fragrances has decreased, according to research published in the April issue of the Journal of the American Academy of Dermatology.

Abstract
Full Text (subscription or payment may be required)

Short-Course Imiquimod Found Effective on Full Face, Scalp

FRIDAY, April 2 (HealthDay News) -- In patients with actinic keratoses, a short-course regimen of imiquimod 2.5 or 3.75 percent may be an effective treatment for the balding scalp or full face, according to research published in the April issue of the Journal of the American Academy of Dermatology.

Abstract - Hanke
Full Text (subscription or payment may be required)
Abstract - Swanson
Full Text (subscription or payment may be required)

MEDI-545 Found Acceptably Safe in Chronic Psoriasis

THURSDAY, April 1 (HealthDay News) -- MEDI-545 -- a fully human anti-interferon-α monoclonal antibody -- appears safe in patients with chronic plaque psoriasis but does not significantly inhibit the type I interferon gene signature in these patients, suggesting that interferon-α (IFN-α) doesn't play a significant role in maintaining the disease, according to research published in the March issue of the Journal of the American Academy of Dermatology.

Abstract
Full Text (subscription or payment may be required)

Copyright © 2010 ScoutNews, LLC. All rights reserved.


Previous: April 2010 Briefing - Cardiology Next: April 2010 Briefing - Diabetes & Endocrinology

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

  • Ask a Doctor Teams: Respond to patient questions and discuss challenging presentations with other members.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2014
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.